Table 2.
Meta-analyses of secondary outcomes
| Meta-analysis | Comparisons (N) | Patients (N) | SMDa | 95% CI | I2 (%) | 95% CI | p |
|---|---|---|---|---|---|---|---|
| PTSD (follow-up) | 13 | 711 | −1.08 | −1.81 to −0.35 | 83 | 72–89 | 0.004 |
| Depression (follow-up) | 8 | 371 | −1.28 | −2.27 to −0.30 | 88 | 79–93 | 0.010 |
| Anxiety (follow-up) | 3 | 171 | −0.49 | −0.93 to −0.05 | 70 | 0–91 | 0.030 |
| Drop-out rate (RR) | 25 | 1636 | 0.96 | 0.82 to 1.13 | 0 | 0–52 | 0.620 |
| Functioning (post-treatment) | 4 | 547 | −0.17 | −0.58 to 0.24 | 74 | 27–91 | 0.420 |
| Functioning (follow-up) | 1 | 25 | −0.81 | −1.63 to 0.01 | NA | NA | 0.050 |
| Quality of life (post-treatment)b | 5 | 173 | 0.23 | −0.08 to 0.54 | 0 | 0–79 | 0.140 |
| Quality of life (follow-up)b | 5 | 174 | 0.27 | −0.08 to 0.63 | 17 | 0–83 | 0.130 |
N, number; SMD, standardised mean difference; CI, confidence interval; PTSD, post-traumatic stress disorder.
a
Negative values favour active interventions.
b
Positive values favour active interventions.